0001209191-20-054997.txt : 20201015
0001209191-20-054997.hdr.sgml : 20201015
20201015202733
ACCESSION NUMBER: 0001209191-20-054997
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201015
FILED AS OF DATE: 20201015
DATE AS OF CHANGE: 20201015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frazier Life Sciences IX, L.P.
CENTRAL INDEX KEY: 0001720320
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 201242557
BUSINESS ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: 206-254-7200
MAIL ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FHMLS IX, L.P.
CENTRAL INDEX KEY: 0001782789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 201242558
BUSINESS ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: 206-254-7200
MAIL ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FHMLS IX, L.L.C.
CENTRAL INDEX KEY: 0001782791
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 201242559
BUSINESS ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: 206-254-7200
MAIL ADDRESS:
STREET 1: 601 UNION STREET
STREET 2: SUITE 3200
CITY: SEATTLE
STATE: WA
ZIP: 98101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Topper James N
CENTRAL INDEX KEY: 0001341382
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 201242560
MAIL ADDRESS:
STREET 1: 550 HAMILTON AVENUE, SUITE 100
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heron Patrick J
CENTRAL INDEX KEY: 0001365617
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 201242561
MAIL ADDRESS:
STREET 1: 550 HAMILTON AVE., SUITE 100
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001819790
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 814717861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 409-9820
MAIL ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-10-15
0
0001819790
Tarsus Pharmaceuticals, Inc.
TARS
0001720320
Frazier Life Sciences IX, L.P.
601 UNION STREET, SUITE 3200
SEATTLE
WA
98101
0
0
1
0
0001782789
FHMLS IX, L.P.
601 UNION STREET, SUITE 3200
SEATTLE
WA
98101
0
0
1
0
0001782791
FHMLS IX, L.L.C.
601 UNION STREET, SUITE 3200
SEATTLE
WA
98101
0
0
1
0
0001341382
Topper James N
601 UNION STREET, SUITE 3200
SEATTLE
WA
92101
0
0
1
0
0001365617
Heron Patrick J
601 UNION STREET, SUITE 3200
SEATTLE
WA
98101
0
0
1
0
Series B Preferred Stock
Common Stock
1390376
D
Series C Preferred Stock
Common Stock
214281
D
The Series B Preferred Stock shall automatically convert into shares of Common Stock, on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock has no expiration date.
The shares are held directly by Frazier Life Sciences IX, L.P. ("FLS LP"). The general partner of FLS LP is FHMLS IX, L.P., and the general partner of FHMLS IX, L.P. is FHMLS IX, LLC. James Topper and Patrick Heron are the sole managing members of FHMLS IX, LLC, and share voting and dispositive power over the shares held by FLS LP. Each of Dr. Topper, Mr. Heron, FHMLS IX, L.P. and FHMLS IX, LLC disclaim beneficial ownership of the shares held by FLS LP, except to the extent of their pecuniary interest therein
The Series C Preferred Stock shall automatically convert into shares of Common Stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series C Preferred Stock has no expiration date.
/s/ James N. Topper, as Managing Director of FHMLS IX, L.L.C., the general partner of FHMLS IX, L.P., the general partner of Frazier Life Sciences IX, L.P.
2020-10-15
/s/ James N. Topper, as Managing Director of FHMLS IX, L.L.C., the general partner of FHMLS IX, L.P.
2020-10-15
/s/ James N. Topper, as Managing Director
2020-10-15
/s/ James N. Topper
2020-10-15
/s/ Patrick J. Heron
2020-10-15